Novo Genomics x Alborg Diagnostics

Novo Genomics x Alborg Diagnostics | Advancing Genomic R&D in Saudi Arabia
Novo Genomics is proud to announce the signing of a Memorandum of Understanding (MoU) with Alborg Diagnostics to establish a collaborative framework in research and development (R&D) across genomics, biotechnology, and bioinformatics.
This partnership aims to drive joint innovation, scientific discovery, and technology development in molecular biology, precision medicine, and data-driven healthcare, while ensuring the highest standards of ethics, quality, and regulatory compliance — in line with Saudi Vision 2030.
Together, we are committed to strengthening the Kingdom’s biotechnology ecosystem and shaping the future of healthcare through innovation. 🌍